Abstract

BackgroundLimited treatment options are available for patients infected with multidrug (MDR)- or pan-drug (PDR)-resistant bacterial pathogens, resulting in infections that can persist for weeks or months. In order to better understand transmission and evolutionary dynamics of MDR Acinetobacter baumannii (Ab) during long-term infection, we analyzed genomes from a series of isolates from individual patients at isolate-specific, patient-specific, and population levels.MethodsWhole genome analysis of longitudinal isolates (range 2-10 isolates per patient spanning 0-829 days) from 40 patients included detection of single-nucleotide variants (SNVs), insertion sequence (IS) mapping, and gene content changes.ResultsPhylogenetic analysis revealed that a significant fraction of apparently persistent infections are in fact due to re-infection with new strains. SNVs primarily resulted in protein coding changes, and IS events primarily interrupted genes or were in an orientation such that the adjacent gene would be over-expressed. Mutations acquired during infection were over-represented in transcriptional regulators, notably pmrAB and adeRS, which can mediate resistance to the last line therapies colistin and tigecycline, respectively, as well as transporters, surface structures, and iron acquisition genes.ConclusionsMost SNVs and IS events were isolate-specific indicating these mutations did not become fixed on the time scale investigated, yet over-representation of independent mutations in some genes or functional categories suggests that they are under selective pressure. Genome analysis at the population-level suggests that gene transfer including recombination also contributes to Ab evolutionary dynamics. These findings provide important insight into the transmission dynamics of Ab and the identification of patients with repeat infections has implications for infection control programs targeted to this pathogen.Electronic supplementary materialThe online version of this article (doi:10.1186/s13073-016-0279-y) contains supplementary material, which is available to authorized users.

Highlights

  • Limited treatment options are available for patients infected with multidrug (MDR)- or pan-drug (PDR)resistant bacterial pathogens, resulting in infections that can persist for weeks or months

  • Strains A. baumannii strains identified in the University Hospitals Health System (UHHS) Clinical Microbiology Laboratory were stored in an archive since 2007

  • Isolate characteristics Genome sequences were obtained for 136 Acinetobacter baumannii (Ab) isolates from 40 patients (Additional file 1: Table S1 and Additional file 2: Table S2)

Read more

Summary

Introduction

Limited treatment options are available for patients infected with multidrug (MDR)- or pan-drug (PDR)resistant bacterial pathogens, resulting in infections that can persist for weeks or months. Bacterial pathogens resistant to multiple classes of antibiotics are increasingly detected in clinical settings, and patients with multidrug-resistant (MDR) infections have limited treatment options. This occurrence can translate into prolonged infections with increased morbidity and mortality [1, 2]. Acinetobacter baumannii (Ab), one of the ESKAPE pathogens, emerged to become a predominant cause of nosocomial infections [11,12,13,14] This is in part due to a remarkable rise in the frequency of MDR (resistant to at least three classes of antibiotic) and extreme drug. Infections with carbapenem-resistant MDR and XDR strains are associated with longer hospitalization, greater economic costs, and higher mortality vs. carbapenem-susceptible strains [15,16,17,18,19,20,21,22,23]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call